Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers (NCT05663502) | Clinical Trial Compass
RecruitingNot Applicable
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
United States200 participantsStarted 2023-05-10
Plain-language summary
This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants must be at least 18 years of age
* Participant must be HIV- positive and have a diagnosed malignancy. If participants are HIV-negative, they must have a newly diagnosed or recurrent malignancy that has an established scientific connection (e.g., shared etiology) to an AIDS- associated malignancy such as:
* classic Kaposi sarcoma
* transplant-associated Kaposi sarcoma,
* anal cancer,
* multicentric Castleman's disease,
* Epstein Barr Virus (EBV) -positive lymphoma
* plasmablastic lymphoma
* Hodgkin's lymphoma.
* For participants that are HIV-positive, HIV infection must be documented by means of any one of the following: :
* Documentation of HIV diagnosis in the medical record by a licensed health care provider;
* Documentation of receipt of antiretroviral therapy (ART) by a licensed health care provider (Documentation may be a record of an ART prescription in the participant's medical record, a written prescription in the name of the participant for ART, or pill bottles for ART with a label showing the participant's name. Receipt of at least two agents is required; each component agent of a multi-class combination ART regimen will be counted toward the 2-agent requirement, excepting receipt of a pre-exposure prophylaxis (PrEP) regimen alone \[e.g., Truvada\], which is exclusionary);
* HIV ribonucleic acid (RNA) detection by a licensed HIV RNA assay demonstrating \> 1000 RNA copies/mL;
* Any licen…
What they're measuring
1
Number of biospecimens collected
Timeframe: Through study completion, anticipated to be 10 years